KMTS Kestra Medical Technologies Ltd.

  1. Stocks
  2. Healthcare
  3. NASDAQ: KMTS

Price (delayed)

$25.51

Market cap

$1.52B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.67

Enterprise value

$1.53B

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 69
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 17
Highlights
The gross profit has soared by 99% year-on-year and by 18% since the previous quarter
Kestra Medical Technologies's revenue has surged by 61% YoY and by 12% QoQ
Kestra Medical Technologies's EPS has increased by 41% YoY but it has decreased by 10% QoQ
Kestra Medical Technologies's quick ratio has decreased by 32% YoY but it has increased by 6% QoQ
Kestra Medical Technologies's debt has soared by 71% YoY and by 63% from the previous quarter
Kestra Medical Technologies's net income has decreased by 26% YoY and by 14% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://kestramedical.com
Peers: ABT MDT BDX ISRG

Key stats

What are the main financial stats of KMTS

KMTS stock price

How has the Kestra Medical Technologies stock price performed over time
Intraday
-2.22%
1 week
5.94%
1 month
-5.48%
1 year
-0.89%
YTD
-3.81%
QTD
0.28%

Financial performance

How have Kestra Medical Technologies's revenue and profit performed over time
Revenue
$106.73M
Gross profit
$57.51M
Operating income
-$143.52M
Net income
-$149.87M
Gross margin
53.9%
Net margin
-140.4%
The gross profit has soared by 99% year-on-year and by 18% since the previous quarter
Kestra Medical Technologies's revenue has surged by 61% YoY and by 12% QoQ
Kestra Medical Technologies's net income has decreased by 26% YoY and by 14% from the previous quarter
KMTS's operating margin is up by 24% YoY and by 5% from the previous quarter

Price vs fundamentals

How does KMTS's price correlate with its fundamentals

Growth

What is Kestra Medical Technologies's growth rate over time

Valuation

What is Kestra Medical Technologies stock price valuation
P/E
N/A
P/B
6.72
P/S
14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.29
Kestra Medical Technologies's EPS has increased by 41% YoY but it has decreased by 10% QoQ
KMTS's equity is up by 21% year-on-year but it is down by 14% since the previous quarter
The price to book (P/B) is 13% higher than the last 4 quarters average of 6.1
Kestra Medical Technologies's revenue has surged by 61% YoY and by 12% QoQ
The stock's price to sales (P/S) is 3.9% less than its last 4 quarters average of 14.9

Efficiency

How efficient is Kestra Medical Technologies business performance
KMTS's return on invested capital has surged by 57% year-on-year and by 22% since the previous quarter
The company's return on assets rose by 38% YoY but it fell by 7% QoQ
Kestra Medical Technologies's return on sales has increased by 21% YoY but it has decreased by 2.3% QoQ
Kestra Medical Technologies's ROE has decreased by 9% from the previous quarter

Dividends

What is KMTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KMTS.

Financial health

How did Kestra Medical Technologies financials performed over time
KMTS's total assets is 178% more than its total liabilities
KMTS's total liabilities has soared by 52% YoY and by 27% from the previous quarter
Kestra Medical Technologies's quick ratio has decreased by 32% YoY but it has increased by 6% QoQ
Kestra Medical Technologies's debt is 66% less than its equity
The debt to equity has soared by 89% from the previous quarter and by 42% YoY
Kestra Medical Technologies's debt has soared by 71% YoY and by 63% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.